baber/WOPTO huggingface dataset:
Patent AU-5260601-A (AU)
Title: Medicinal compositions promoting bowel movement
Inventor: YASUDA MASAHIRO
IPC: A61P43/00
Filed: 2001-04-26
Abstract: The present invention relates to uses of adenosine A 2  receptor antagonists, in particular, adenosine A 2b  receptor antagonists, for the preparation of a medicament having defecation-promoting activity, for example for treating, preventing or improving constipation, irritable bowel syndrome or a symptom where defecation is difficult and/or rare, and also for evacuating intestinal tracts at the time of examination of digestive tracts, or before or after an operation.  The adenosine A 2  receptor antagonists for use according to the invention exhibit a gentle but strong defecation-promoting action without causing diarrhea.
Patent AU-5268779-A (AU)
Title: Composition of paracetamol and metoclopramide
Inventor: PATHAK RAM DUTTA
IPC: A61K33/00
Filed: 1979-11-09
Abstract: Effervescent analgesic powders which comprise paracetamol D.C., and metoclopramide or an acid addition salt thereof, the weight ratio of paracetamol D.C. to metoclopramide or the acid addition salt thereof lying in the range 50:1 to 250:1, and a process for their preparation.
Patent AU-5270790-A (AU)
Title: Coded marking supports and device for making the coded marks
Inventor: MOROSINI FLAVIO
IPC: G09F3/04
Filed: 1990-03-02
Abstract: A marking support (43) is comprised of a plate (5) on which may be ratched a plurality of aligned identification elements (1). In an alternate embodiment, the plate (5) is provided with clamping members (10) allowing to fix the marking support (43) to a cable, the plate (5) being substantially parallel to the cable.
Patent AU-5321096-A (AU)
Title: Oral compositions
Inventor: HUGHES IAIN ALLAN
IPC: A61K8/00
Filed: 1996-03-20
Abstract: An oral composition in the form of a toothpaste, powder, liquid dentifrice, mouthwash, denture cleaner, chewing gum or candy comprising one or more oral composition components selected from abrasives, binders, humectants, surfactants, fluoride ion sources, anti-calculus agents and sweeteners and additionally comprising: a dimethicone copolyol selected from alkyl- and alkoxy-dimethicone copolyols having formula (I).
Patent AU-5503790-A (AU)
Title: Lytic agents and uses thereof
IPC: G01N33/50
Filed: 1990-05-15
Abstract: The invention comprises a lytic agent and method of performing a differential cell subpopulation count, of use for example in flow cytometry. The lytic agent comprises an aromatic oxyethanol, an organic buffer with a pK at or near 8.5, and a nonionic detergent. Preferably, the aromatic oxyethanol is 2-phenoxyethanol. The method and lytic agent allow the five part differential determination of leukocyte cell subpopulations from a whole blood sample using flow cytometry methods.
Patent AU-5611900-A (AU)
Title: A structured peptide scaffold for displaying turn libraries on phage
Inventor: COCHRAN ANDREA G
IPC: C07K14/735
Filed: 2000-06-13
Abstract: The invention is directed to a model system for structure-activity analysis of peptide or protein molecules involved in important biological processes. Provided by the invention are combinatorial peptide libraries comprising disulfide-constrained cyclic peptides with sequences favorable for energy stabilized conformations. A preferred embodiment of the invention is directed to peptides containing beta-turn tetrapeptide that form structured beta-hairpin scaffold in solution. Methods of selecting and using such peptides are provided herein, which are useful for mimicking in vivo molecular interactions and designing therapeutic agents. Thus, the invention has profound utility for biological studies and drug development.
Patent AU-5640799-A (AU)
Title: Microparticles
Inventor: OSBORNE NICHOLAS DAVID
IPC: A61K9/14
Filed: 1999-09-03
Abstract: Microparticles comprising or consisting of a therapeutic agent, having a relative particle density of at least 80% of the agent, and a shape factor of 1-5, are new. Independent claims are also included for: (1) a needleless syringe comprising microparticles as above; (2) production of the microparticles comprising spray-drying a solution or a suspension comprising the therapeutic agent.
Patent AU-5753886-A (AU)
Title: Wrapping an intra-aortic balloon catheter
Inventor: CHO GEORGE ENG SAO
IPC: A61M60/843
Filed: 1986-05-19
Abstract: An apparatus for wrapping a balloon catheter such as an intra-aortic balloon catheter is disclosed. The wrapping apparatus comprises a housing having a channel which receives the balloon membrane of the intra-aortic balloon. The wrapping apparatus also includes a clutching means located in the channel for exerting a predetermined pressure on the balloon membrane to enable the balloon membrane to be wrapped as the wrapping apparatus is rotated relative to the balloon catheter. The clutching means also permits relatively free rotation of the balloon membrane within the wrapping apparatus after the balloon membrane has been wrapped.The clutching means can include a shoe and a biasing means for biasing the shoe towards the balloon membrane with a predetermined pressure while the balloon membrane is being wrapped, yet enable the balloon membrane to rotate relatively freely within the wrapping apparatus after the balloon membrane has been wrapped to a predetermined degree.The clutching means, alternatively, can include flexible vanes projecting inwardly within the channel such that the vanes contact the balloon membrane during wrapping and provide a predetermined pressure onto the balloon membrane which aids in wrapping yet permits the wrapped balloon membrane to rotate relatively freely within the wrapping apparatus.
Patent AU-5926496-A (AU)
Title: Peptide radiopharmaceutical applications
Inventor: ZAMORA PAUL O
IPC: A61K38/00
Filed: 1996-05-22
Abstract: The invention relates to radiotherapy with somatostatin-derived peptides labeled with medically useful metal ions. The invention in particular provides for methods and reagents for labeling somatostatin-derived peptides with perrhenate, in which a solution including somatostatin-derived peptide analogue containing at least one disulfide bond is provided, the solution is reacted with stannous ions and with a radioisotope, wherein the stannous ions are sufficient to substantially reduce the disulfide bonds of the peptide and the radioisotope, and the radiolabeled somatostatin-derived peptide analogue recovered. Also provided are methods for regional administration of radiolabeled somatostatin-derived peptides, methods for enhanced regional retention of radiolabeled somatostatin-derived peptides, methods for treatment of arthritis using radiolabeled somatostatin derived peptides, and methods for stabilizing radiolabeled somatostatin derived peptides.
Patent AU-6015694-A (AU)
Title: Process for producing alkenyl aromatic foams using a combination of atmospheric and orgnic gases and foams produced thereby
Inventor: REEDY MICHAEL E
IPC: C08J9/12
Filed: 1993-12-22
Abstract: There is disclosed a process for producing alkenyl aromatic foams utilizing a combination of atmospheric and organic gases as blowing agent, preferably using greater than 30% by weight of atmospheric gas, and preferably also using a predetermined about of a masterbatch mix comprising a styrenic polymer, a rubbery block copolymer, and a solid blowing agent. Also disclosed are alkenyl aromatic foams produced by the process which exhibit increased densities, increased thermoforming capabilities, increased post-expansion properties, and increased retainment of the atmospheric and organic gases.
Patent AU-6047196-A (AU)
Title: Therapeutic fragments of von willebrand factor
Inventor: FARB DAVID L
IPC: A61K38/36
Filed: 1996-06-06
Abstract: Processes for preparing aqueous solutions of cysteine-altered von Willebrand Factor fragment which are substantially free of aggregate and capable of therapeutic use for treating thrombosis are provided. The claimed process comprises providing an aqueous solution of vWF fragment and denaturant and containing undesired contaminants, said solution having an acidic pH; separating said contaminants from said solution by contacting said solution with an affinity chromatography medium to which said vWF fragments adhere; eluting said vWF fragment from said affinity chromatography medium in the presence of the denaturant; and separating the eluted fragment from said denaturant while maintaining the aqueous solution of the fragment at a pH of about 2.5 to less than about 5.5 to increase monomerization of, and decrease aggregation of, said fragment, thereby forming an aqueous solution of vWF fragment which is substantially free of aggregate.
Patent AU-6099094-A (AU)
Title: Modular device for the ease of use and installation of filtration textiles
Inventor: GERAKIOS MICHAEL
IPC: B01D33/17
Filed: 1994-01-26
Abstract: A modular table filter for a circular horizontal rotating table filter includes a number of sections which may be assembled on the support frame thereof. The sections are annular-sector-shaped and, when assembled, form an annulus on the table filter. Each section, in turn, may be broken down into an outer subsection and an inner subsection. Filtration fabric, or textile, may be placed on top of the outer subsection, and secured therein by the inner subsection, which is designed to lock thereinto. Alternatively, each section may be an integral annular-sector-shaped frame having a peripheral groove or channel. Filtration textile may be placed on top of the frame, and over the groove or channel, and wedges driven thereinto to hold the fabric tautly across the frame. The modular table filter greatly simplifies the replacement of the filtration fabric, as the sections holding fabric needing replacement may be removed easily and replaced by ones having fresh filtration textiles without the need for isolating the table filter for an inordinately long time.
Patent AU-6144494-A (AU)
Title: Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
Inventor: BRIAND PASCALE
IPC: A61K35/76
Filed: 1994-02-28
Abstract: The use of defective recombinant adenoviruses containing an inserted gene for preparing a pharmaceutical useful for treating eye diseases is disclosed.
Patent AU-6288886-A (AU)
Title: Garden shower connected to a solar collector and provided with a mixing tap
Inventor: ZVOLENSZKY ISTVAN
IPC: E03C1/044
Filed: 1986-09-08
Abstract: The garden shower is connected to a solar collector and is provided with a mixing tap. The free flowing shower device is actuated by the water pressure of the mains and is provided with a vertical pipe (5) with a shower head and inlet and outlet hot and cold water pipes (1, 3, 4). The device is characterized in that it comprises a mixing tap (2) for taking hot water out of the solar collector and also for mixing cold water and hot water. The tap (2) comprises a knob (6) which may rotate mounted in the inlet and outlet conduit and presenting a blind bore and two bores (7, 8) perpendicular to the plane of the blind bore and connected to the latter and forming between each other an obtuse angle.
Patent AU-6447600-A (AU)
Title: Device for arresting the propagation of a buckle in a double-walled pipe
Inventor: BASTARD ANTOINE
IPC: F16L1/14
Filed: 2000-06-13
Abstract: Device for arresting the propagation of a buckle in a double walled pipe. The device comprising an outer pipe wall having a defined external diameter and placed around an inner pipe wall, defining an annular space between the said outer and inner walls; providing predetermined regions in the annular space which are bounded between two sealing blocks with radially opposed faces which are in contact with the outer and inner pipes; placing a curable compound in each region and curing it the length of each region is at least equal to 0.5 times the external diameter of the outer wall.
Patent AU-6462486-A (AU)
Title: Method of preparing alpha-1-proteinase inhibitor
Inventor: COAN MICHAEL H
IPC: A61K38/00
Filed: 1986-10-31
Abstract: There is disclosed a method for separating alpha-l-­proteinase inhibitor (also known as alpha-l antitrypsin) from an aqueous solution of plasma proteins, especially from Cohn Effluent II & III and Cohn Effluent I. The method includes the steps of first treating the aqueous solution to lower the concentration of salts therein and, optionally, its alcohol content, contacting the resulting solution with an anion exchange resin having selective affinity for alpha-l-proteinase inhibitor to selectively bind the alpha-l-proteinase inhibitor and allow unwanted plasma proteins to elute through the resin, displacing the alpha-l-proteinase inhibitor from the resin and recovering the same.
Patent AU-6491886-A (AU)
Title: Device and process for the continuous casting of metals
Inventor: SAUTEBIN RAOUL
IPC: B22D11/01
Filed: 1986-11-07
Abstract: A device for contactless, vertically downwards continuous casting of metals in an electromagnetic alternating field, has an inductor and an electrically conductive, non-ferromagnetic screen that tapers downwards and features at a vertical distance 9 from this screen an electrically conductive, non-ferromagnetic counter screen that tapers upwards, the distance 9 between the said screen and counter screen being at least 2 mm, at most equal of the height of the inductor and in a continuous process which employs this device the circulation of the melt in the molten head of the ingot is reduced at least in the steady-state phase of casting. The process is particularly suitable for continuous casting aluminum alloys having a magnesium content of at least 2%.
Patent AU-6602990-A (AU)
Title: Sleeve-type carrier with integral alignment feature
Inventor: SCHUSTER RICHARD LEE
IPC: B65D71/00
Filed: 1990-09-20
Abstract: An enclosed article carrier having upper sloping and panels to conform to the shape of the end articles in the carrier. The end panels are comprised of dust flaps adhered to overlapping upper and lower end flaps. Each dust flap is connected to the adjacent edge of its side panel along angled fold lines, the bottom edge of the dust flap being connected to the side panel adjacent the bottom panel of the carrier. Each dust flap has a cutout extending from its outer edge to a point spaced from the juncture of the fold lines. The carriers are thus strong enough to resist bowing during loading, resulting in well-aligned end panel flaps.
Patent AU-6621096-A (AU)
Title: Use of calendula glycosides for the treatment of psoriasis
Inventor: HABTEMARIUM SOLOMON
IPC: C07H15/26
Filed: 1996-07-24
Abstract: A method and compound for the treatment of disease involving hyperproliferation of dermis cells is provided. In particular, compounds isolated from the species of plants known as calendula have been found to be beneficial in the treatment of psoriasis. An extract of plant material obtained from calendula officinalis has been found to be advantageous as an active compound in medicaments for use in the treatment of psoriasis.
Patent AU-6645998-A (AU)
Title: Oxygen or sulfur containing heteroaromatics as factor xa inhibitors
Inventor: PRUITT JAMES RUSSELL
IPC: A61P7/02
Filed: 1997-12-18
Abstract: The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula (I), or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(=NH)NH2, which are useful as inhibitors of factor Xa.                              00000
Patent AU-6666796-A (AU)
Title: Method of converting a series of M-bit information words to a modulated signal, method of producing a record carrier, coding device, device, recording device, signal, as well as a record carrier
IPC: H03M7/20
Filed: 1996-08-26
Abstract: A method of converting a series of m-bit information words to a modulated signal. For each information word from the series an n-bit code word is delivered. The delivered code words are converted to the modulated signal. The code words are distributed over at least one group of a first type and at least one group of a second type. For the delivery of each of the code words belonging to the group of the first type the associated group establishes a coding state of the first type. When each of the code words belonging to the group of the second type is delivered, a coding state of the second type is established which is determined by an information word belonging to the delivered code word. When one of the code words is assigned to the received information word, this code word is selected from a set of code words based on the coding state. The sets of code words belonging to the coding states of the second type are disjunct. The DC and LF parameters of the modulated signal improve when in a coding state of the first type, by assigning a code word from a set of another state of the first type, while maintaining the dk-constraint. Selecting one of the sets of the first type results in the best momentary running DC value. The method can be applied to different coding state mechanisms.
Patent AU-6722994-A (AU)
Title: Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
Inventor: LIVEY IAN
IPC: A61P31/04
Filed: 1994-04-29
Abstract: An approach to Borrelia vaccine formulation taking into account serological, genotypic and epidemiological information by which OspC proteins from different strains of B. burgdorferi are grouped together. OspC antigens are chosen in order to constitute a representative sample of such groupings, so that the resulting vaccine provides the greatest cross-protectivity with the fewest number of antigens.
Patent AU-6912887-A (AU)
Title: 1-arylpyrazoles
Inventor: GEHRING REINHOLD
IPC: C07D231/44
Filed: 1987-02-23
Abstract: Insecticidally and acarididally active 1-arylpyrazoles of the formula <IMAGE>   in which R1 represents hydrogen, alkyl or halogen alkyl, R2 represents alkyl, alkenyl, alkinyl, cycloalkyl, halogenoalkyl, halogenoalkenyl, alkoxyalkyl, alkylthioalkyl, alkylsulphinylalkyl, alkylsulphonylalkyl, optionally substituted aralkyl or optionally substituted aryl, R3 represents alkyl, alkenyl, alkinyl, halogenoalkyl, halogenoalkenyl, alkoxyalkyl, alkylthioalkyl, cycloalkyl or optionally substituted aralkyl, R4 represents alkyl, alkenyl, alkinyl, halogenoalkyl, halogenoalkenyl, alkoxyalkyl, alkylthioalkyl, cycloalkyl or optionally substituted aralkyl, and, in addition, also represents hydrogen in the case where R3 does not simultaneously represent unsubstituted alkyl, or R3 and R4, together with the nitrogen atom to which they are bound, represent a saturated heterocycle, which can optionally contain further heteroatoms, Ar represents in each case optionally substituted phenyl or pyridyl, and n represents a number 0, 1 or 2.
Patent AU-7078396-A (AU)
Title: Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes
Inventor: NANTZ MICHAEL H
IPC: C07C217/42
Filed: 1996-09-23
Abstract: Amine containing compounds and their use in the generation of cytofectin:polynucleotide complexes for transfection of cells, formulations, counterions, and reaction conditions for maximizing the transfection include using cationic amine compounds that have general structure (I), wherein R4 and R5 are a pair of same or different lipoyl moieties selected from a group consisting of an alkyl, alkenyl, alkynyl, alkanoyl, alkenoyl, or alkynoyl groups and for R1, R2, and R3 at least two are hydroxylated, ether containing, or acyloxy containing alkyl, alkynyl, or alkynyl groups or at least one amine bonded halogen containing moiety selected from a group consisting of a halogenated alkyl, alkenyl, or alkynyl group or a mixture of at least one halogen containing moiety selected from a group consisting of a halogenated alkyl, alkenyl, or alkynyl group and at least one hydroxylated, ether containing, or acyloxy containing alkyl, alkenyl, or alkynyl group, and X<-> is an oxyanion or halide counterion.
Patent AU-7080400-A (AU)
Title: Chemically inert megasonic transducer system
Inventor: BECK MARK J
IPC: B06B3/02
Filed: 2000-08-25
Abstract: A megasonic cleaning system comprised of a container, a resonator, a piezoelectric crystal and an indium layer for attaching the resonator to the piezoelectric crystal. The container includes a fluid chamber for holding a volume of cleaning solution. The resonator is selected from the group consisting of sapphire, quartz, silicon carbide, silicon nitride and ceramic. The resonator forms the bottom of the container and has an interface surface which abuts the fluid chamber.
Patent AU-7186481-A (AU)
Title: Indole and indoline carboxylic acid derivatives
Inventor: ASHTON M J
IPC: C07D209/08
Filed: 1981-06-16
Abstract: Indole and indoline derivatives of the formula:  <IMAGE>  wherein indicates a double bond or a single bond between carbon atoms, R1 represents hydrogen, alkyl of 1 through 6 carbon atoms, or alkyl of 1 through 6 carbon atoms substituted by one or more than one of the same type of substituents selected from the hydroxy group, alkenyl groups of 2 through 5 carbon atoms, and alkanoyloxy groups of 2 through 7 carbon atoms, and one of the symbols R2 represents alkyl of 6 through 24 carbon atoms and the other symbol R2 represents alkyl of 1 through 24 carbon atoms or hydrogen, and R3 represents alkyl of 1 through 6 carbon atoms or hydrogen, are new compounds possessing useful pharmacological properties. They are of use in the treatment of diabetes mellitus, hyperlipoproteinaemic states, of atherosclerosis, and of associated conditions.
Patent AU-7431698-A (AU)
Title: Container closure
Inventor: HAHN HANS-ULRICH
IPC: B67D1/08
Filed: 1998-04-22
Abstract: A description is given of a container closure for filling and emptying containers, in particular drum-like transporting containers, which can be inserted in an exchangeable manner into a container opening, which receives a plug head. The container closure has a riser tube, which is connected to the plug head, and a removal connection element, it being the case that the latter can be locked to the plug head by means of a stud coding system which has coding studs and matching coding recesses. According to the invention, the coding studs are provided on a first securing part and the coding recesses are provided on a second securing part. One of the securing parts is designed as an annular disc, which can separately be fitted loosely, such that it cannot slip off, onto the modular removal connection element. The other of the securing parts is integrated in the plug head. The container closure described avoids mix-up of chemicals, permits simultaneous liquid removal and ventilation, and, while complying with the regulations for licensing hazardous substances, can be connected to commercially available containers or drums.
Patent AU-7588101-A (AU)
Title: Ion channel assay methods
Inventor: MAHER MICHAEL P
IPC: G01N37/00
Filed: 2001-07-09
Abstract: A method of characterizing the biological activity of a candidate compound may include exposing cells to the candidate compound, and then exposing the cells to a repetitive application of electric fields so as to set the transmembrane potential to a level corresponding to a pre-selected voltage dependent state of a target ion channel.
Patent AU-7589191-A (AU)
Title: Process for the preparation of high-purity tetrahydrofuran
Inventor: FALLING STEPHEN NEAL
IPC: B01J23/42
Filed: 1991-03-28
Abstract: Disclosed is a process for the preparation of high-purity tetrahydrofuran from a mixture of 2,5-dihydrofuran and 3,4-epoxy-1-butene and/or crotonaldehyde wherein the mixture is hydrogenated in the presence of a nickel or platinum catalyst to obtain a product consisting essentially of tetrahydrofuran and 1-butanol which are readily separable.
Patent AU-7704701-A (AU)
Title: Using embedded data with file sharing
Inventor: LEVY KENNETH L
IPC: G06F21/10
Filed: 2001-07-20
Abstract: A method of controlling use of a media file in a file sharing system, the method comprising: in a client of the file sharing system, computing a fingerprint of media data; using the fingerprint to look up a related information in a database; and performing an action associated with the related information.